ID   HEK-293 hNav1.9
AC   CVCL_YN15
SY   HEK-hNav1.9; HEK-hNav1.9 (+hbeta1/beta2)
DR   Wikidata; Q94092075
RX   PubMed=27556810;
RX   PubMed=30503201;
CC   Transfected with: HGNC; 10583; SCN11A.
CC   Transfected with: HGNC; 10586; SCN1B.
CC   Transfected with: HGNC; 10589; SCN2B.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=27556810; DOI=10.1371/journal.pone.0161450;
RA   Lin Z.-X., Santos S., Padilla K., Printzenhoff D., Castle N.A.;
RT   "Biophysical and pharmacological characterization of Nav1.9 voltage
RT   dependent sodium channels stably expressed in HEK-293 cells.";
RL   PLoS ONE 11:E0161450-E0161450(2016).
//
RX   PubMed=30503201; DOI=10.1016/j.ebiom.2018.11.042;
RA   Namer B., Schmidt D., Eberhardt E., Maroni M., Dorfmeister E.,
RA   Kleggetveit I.P., Kaluza L., Meents J.E., Gerlach A., Lin Z.-X.,
RA   Winterpacht A., Dragicevic E., Kohl Z., Schuttler J., Kurth I.,
RA   Warncke T., Jorum E., Winner B., Lampert A.;
RT   "Pain relief in a neuropathy patient by lacosamide: proof of principle
RT   of clinical translation from patient-specific iPS cell-derived
RT   nociceptors.";
RL   EBioMedicine 39:401-408(2019).
//